Compound pharmacy is still a viable industry but it highly regulated and reimbursements have been cut to the bone. FYI - a couple of our sharp investors who are/were in this industry predicted this decline in reimbursements and loss of revenues. ExpressScripts cut reimbursements 80%. And, it didn't just impact ScripsAmerica, it was industry wide. Companies who were generating $5M a month are now seeing revenues <$1M per month. It is what it is.